Core B: Developmental ABSTRACT The Developmental Core (Core B) is the keystone of Penn CFAR activities catalyzing new research directions in HIV/AIDS priority areas, enhancing the research pipeline through mentoring programs that ensure the next generation of HIV investigators and research leaders and attracting new-to-AIDS investigators, and advancing Penn CFAR strategic scientific priorities. The Developmental Core has been critical for the establishment of new independent HIV/AIDS investigators and new research areas by its mentoring, partnering and funding activities. Since creation of the Core in 1999, it has funded 101 pilot grants with a total of $3.96M, yielding $82.4M in subsequent NIH funds for a 21:1 return on investment (ROI); over the past 10 years it has funding 62 pilot grants with $2.5M, resulting in NIH grants totaling $62.4M (25:1 ROI). Core B is led by Drs. Pablo Tebas (Director) and Luis Montaner (Co-Director). The Developmental Core aims are: 1. To train and mentor the next generation of HIV investigators and leaders in AIDS research, encourage entry of established investigators from other areas into HIV/AIDS research, and enhance the diversity of investigators in the field through: (1) Education, mentoring, and partnering programs to provide advice, support and leadership for emerging and new-to-AIDS investigators; (2) Broadly engaging the CFAR community in mentoring through collaboration and coordination with other Cores and CFAR faculty; (3) Implementing a series of Workshops, Working Groups, and Review Panels that bring together investigators from interrelated areas in order to give feedback to new investigators and to nurture interdisciplinary interactions. 2. To provide novel funding mechanisms that support innovative research initiatives, and serve as a vehicle for research training through: (1) The Developmental Pilot Grant program that funds up to 6 developmental projects each year, targeting new and new-to-HIV investigators, and/or new interdisciplinary teams; (2) A Partnership Pilot Grant program that leverage resources and create synergy with other groups on the CFAR campus; (3) A novel Microgrant Grant Program to provide nimble, rapid funding for junior investigators to obtain targeted data for resubmission of a grant or support presentations at important scientific meetings. 3. To catalyze research in CFAR and NIH HIV/AIDS research priority areas and the development of interdisciplinary collaborative research, and engage campus and community partners by: (1) Creating an environment that brings together investigators from the basic, clinical and behavioral sciences; (2) Engaging campus researchers and Philadelphia community partners in outreach to Schools, Departments and Divisions on campus, and enhancing collaborations with the Philadelphia Department of Public Health and community- based AIDS service organizations; (3) Directing mentorship activities and funding initiatives to support new investigators and to develop careers in HIV/AIDS priority research areas; (4) Directing funding initiatives to priority areas for the CFAR including its Scientific Working Groups.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI045008-22
Application #
9925287
Study Section
Special Emphasis Panel (ZAI1)
Project Start
1999-07-01
Project End
2024-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
22
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Papasavvas, Emmanouil; Lada, Steven M; Joseph, Jocelin et al. (2018) Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV. AIDS :
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187
Bengsch, Bertram; Ohtani, Takuya; Khan, Omar et al. (2018) Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. Immunity 48:1029-1045.e5
Brocca-Cofano, Egidio; Xu, Cuiling; Wetzel, Katherine S et al. (2018) Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques. J Virol 92:
Costea, Paul I; Hildebrand, Falk; Arumugam, Manimozhiyan et al. (2018) Enterotypes in the landscape of gut microbial community composition. Nat Microbiol 3:8-16
Page, Kathleen R; Grieb, Suzanne Dolwick; Nieves-Lugo, Karen et al. (2018) Enhanced immigration enforcement in the USA and the transnational continuity of HIV care for Latin American immigrants in deportation proceedings. Lancet HIV 5:e597-e604
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
Opondo, Philip R; Ho-Foster, Ari R; Ayugi, James et al. (2018) HIV Prevalence Among Hospitalized Patients at the Main Psychiatric Referral Hospital in Botswana. AIDS Behav 22:1503-1516
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351
Clarke, Erik L; Lauder, Abigail P; Hofstaedter, Casey E et al. (2018) Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low-Microbial Content Samples. Am J Respir Crit Care Med 197:225-234

Showing the most recent 10 out of 775 publications